nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP2D6—breast cancer	0.121	0.389	CbGaD
Ranitidine—CYP3A4—breast cancer	0.104	0.334	CbGaD
Ranitidine—ABCB1—breast cancer	0.0863	0.278	CbGaD
Ranitidine—CYP1A2—Anastrozole—breast cancer	0.0273	0.0604	CbGbCtD
Ranitidine—CYP1A2—Toremifene—breast cancer	0.025	0.0552	CbGbCtD
Ranitidine—CYP3A5—Lapatinib—breast cancer	0.0245	0.0541	CbGbCtD
Ranitidine—ABCB1—Toremifene—breast cancer	0.0219	0.0483	CbGbCtD
Ranitidine—CYP2C19—Lapatinib—breast cancer	0.0198	0.0437	CbGbCtD
Ranitidine—CYP3A4—Exemestane—breast cancer	0.0189	0.0417	CbGbCtD
Ranitidine—CYP2D6—Idarubicin—breast cancer	0.0171	0.0377	CbGbCtD
Ranitidine—CYP3A4—Letrozole—breast cancer	0.0161	0.0355	CbGbCtD
Ranitidine—ABCB1—Lapatinib—breast cancer	0.016	0.0352	CbGbCtD
Ranitidine—CYP3A4—Anastrozole—breast cancer	0.0143	0.0316	CbGbCtD
Ranitidine—CYP3A4—Toremifene—breast cancer	0.0131	0.0289	CbGbCtD
Ranitidine—CYP3A5—Tamoxifen—breast cancer	0.0123	0.0271	CbGbCtD
Ranitidine—CYP3A4—Fulvestrant—breast cancer	0.0122	0.0269	CbGbCtD
Ranitidine—CYP3A4—Thiotepa—breast cancer	0.0109	0.024	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—breast cancer	0.0105	0.0231	CbGbCtD
Ranitidine—CYP3A4—Ixabepilone—breast cancer	0.00993	0.0219	CbGbCtD
Ranitidine—CYP2C19—Tamoxifen—breast cancer	0.0099	0.0219	CbGbCtD
Ranitidine—CYP3A4—Lapatinib—breast cancer	0.00956	0.0211	CbGbCtD
Ranitidine—CYP3A5—Paclitaxel—breast cancer	0.00955	0.0211	CbGbCtD
Ranitidine—CYP3A5—Irinotecan—breast cancer	0.00943	0.0208	CbGbCtD
Ranitidine—CYP1A2—Tamoxifen—breast cancer	0.00914	0.0202	CbGbCtD
Ranitidine—ABCB1—Vinorelbine—breast cancer	0.00885	0.0195	CbGbCtD
Ranitidine—CYP2D6—Vinorelbine—breast cancer	0.00834	0.0184	CbGbCtD
Ranitidine—ABCB1—Tamoxifen—breast cancer	0.00799	0.0176	CbGbCtD
Ranitidine—ABCB1—Mitoxantrone—breast cancer	0.00779	0.0172	CbGbCtD
Ranitidine—CYP2D6—Tamoxifen—breast cancer	0.00753	0.0166	CbGbCtD
Ranitidine—CYP3A4—Raloxifene—breast cancer	0.00724	0.016	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—breast cancer	0.00691	0.0153	CbGbCtD
Ranitidine—ABCB1—Gemcitabine—breast cancer	0.00688	0.0152	CbGbCtD
Ranitidine—CYP1A2—Fluorouracil—breast cancer	0.00673	0.0149	CbGbCtD
Ranitidine—ABCB1—Paclitaxel—breast cancer	0.00622	0.0137	CbGbCtD
Ranitidine—ABCB1—Irinotecan—breast cancer	0.00613	0.0135	CbGbCtD
Ranitidine—ABCB1—Vinblastine—breast cancer	0.00545	0.012	CbGbCtD
Ranitidine—CYP3A4—Vinorelbine—breast cancer	0.0053	0.0117	CbGbCtD
Ranitidine—CYP2D6—Vinblastine—breast cancer	0.00514	0.0113	CbGbCtD
Ranitidine—CYP3A4—Tamoxifen—breast cancer	0.00479	0.0106	CbGbCtD
Ranitidine—CYP3A4—Mitoxantrone—breast cancer	0.00467	0.0103	CbGbCtD
Ranitidine—ABCB1—Docetaxel—breast cancer	0.0045	0.00993	CbGbCtD
Ranitidine—CYP3A4—Paclitaxel—breast cancer	0.00373	0.00823	CbGbCtD
Ranitidine—CYP3A4—Irinotecan—breast cancer	0.00368	0.00812	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—breast cancer	0.00335	0.0074	CbGbCtD
Ranitidine—CYP3A4—Vinblastine—breast cancer	0.00327	0.00722	CbGbCtD
Ranitidine—ABCB1—Methotrexate—breast cancer	0.00325	0.00717	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—breast cancer	0.00316	0.00697	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—breast cancer	0.00269	0.00595	CbGbCtD
Ranitidine—Nizatidine—BCHE—breast cancer	0.00247	0.719	CrCbGaD
Ranitidine—CYP3A4—Doxorubicin—breast cancer	0.00201	0.00443	CbGbCtD
Ranitidine—Nizatidine—ABCB1—breast cancer	0.000967	0.282	CrCbGaD
Ranitidine—Photosensitivity reaction—Epirubicin—breast cancer	6.54e-05	0.000413	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—breast cancer	6.5e-05	0.000411	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.49e-05	0.00041	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—breast cancer	6.48e-05	0.00041	CcSEcCtD
Ranitidine—Malaise—Capecitabine—breast cancer	6.46e-05	0.000408	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—breast cancer	6.46e-05	0.000408	CcSEcCtD
Ranitidine—Insomnia—Paclitaxel—breast cancer	6.44e-05	0.000407	CcSEcCtD
Ranitidine—Vertigo—Capecitabine—breast cancer	6.44e-05	0.000407	CcSEcCtD
Ranitidine—Hypersensitivity—Irinotecan—breast cancer	6.44e-05	0.000407	CcSEcCtD
Ranitidine—Hypersensitivity—Mitoxantrone—breast cancer	6.44e-05	0.000407	CcSEcCtD
Ranitidine—Vomiting—Thiotepa—breast cancer	6.43e-05	0.000407	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—breast cancer	6.42e-05	0.000406	CcSEcCtD
Ranitidine—Leukopenia—Capecitabine—breast cancer	6.41e-05	0.000405	CcSEcCtD
Ranitidine—Rash—Thiotepa—breast cancer	6.38e-05	0.000403	CcSEcCtD
Ranitidine—Dermatitis—Thiotepa—breast cancer	6.37e-05	0.000403	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—breast cancer	6.37e-05	0.000403	CcSEcCtD
Ranitidine—Dyspnoea—Paclitaxel—breast cancer	6.35e-05	0.000402	CcSEcCtD
Ranitidine—Headache—Thiotepa—breast cancer	6.34e-05	0.000401	CcSEcCtD
Ranitidine—Somnolence—Paclitaxel—breast cancer	6.33e-05	0.0004	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—breast cancer	6.3e-05	0.000398	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—breast cancer	6.3e-05	0.000398	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—breast cancer	6.3e-05	0.000398	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—breast cancer	6.29e-05	0.000398	CcSEcCtD
Ranitidine—Nausea—Vinorelbine—breast cancer	6.29e-05	0.000398	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—breast cancer	6.23e-05	0.000394	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—breast cancer	6.2e-05	0.000392	CcSEcCtD
Ranitidine—Hypersensitivity—Fluorouracil—breast cancer	6.16e-05	0.00039	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—breast cancer	6.13e-05	0.000387	CcSEcCtD
Ranitidine—Sweating—Epirubicin—breast cancer	6.12e-05	0.000387	CcSEcCtD
Ranitidine—Arthralgia—Capecitabine—breast cancer	6.1e-05	0.000386	CcSEcCtD
Ranitidine—Myalgia—Capecitabine—breast cancer	6.1e-05	0.000386	CcSEcCtD
Ranitidine—Chest pain—Capecitabine—breast cancer	6.1e-05	0.000386	CcSEcCtD
Ranitidine—Constipation—Paclitaxel—breast cancer	6.09e-05	0.000385	CcSEcCtD
Ranitidine—Pain—Paclitaxel—breast cancer	6.09e-05	0.000385	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—breast cancer	6.09e-05	0.000385	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—breast cancer	6.05e-05	0.000382	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—breast cancer	6.04e-05	0.000382	CcSEcCtD
Ranitidine—Discomfort—Capecitabine—breast cancer	6.03e-05	0.000381	CcSEcCtD
Ranitidine—Pruritus—Gemcitabine—breast cancer	6.02e-05	0.000381	CcSEcCtD
Ranitidine—Nausea—Thiotepa—breast cancer	6.01e-05	0.00038	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—breast cancer	6e-05	0.000379	CcSEcCtD
Ranitidine—Diarrhoea—Mitoxantrone—breast cancer	5.98e-05	0.000378	CcSEcCtD
Ranitidine—Diarrhoea—Irinotecan—breast cancer	5.98e-05	0.000378	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—breast cancer	5.96e-05	0.000377	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—breast cancer	5.94e-05	0.000376	CcSEcCtD
Ranitidine—Pruritus—Fluorouracil—breast cancer	5.92e-05	0.000374	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—breast cancer	5.91e-05	0.000374	CcSEcCtD
Ranitidine—Confusional state—Capecitabine—breast cancer	5.9e-05	0.000373	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—breast cancer	5.89e-05	0.000373	CcSEcCtD
Ranitidine—Feeling abnormal—Paclitaxel—breast cancer	5.87e-05	0.000371	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—breast cancer	5.84e-05	0.000369	CcSEcCtD
Ranitidine—Diarrhoea—Gemcitabine—breast cancer	5.82e-05	0.000368	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—breast cancer	5.79e-05	0.000366	CcSEcCtD
Ranitidine—Dizziness—Irinotecan—breast cancer	5.78e-05	0.000365	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—breast cancer	5.76e-05	0.000364	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—breast cancer	5.73e-05	0.000362	CcSEcCtD
Ranitidine—Diarrhoea—Fluorouracil—breast cancer	5.72e-05	0.000362	CcSEcCtD
Ranitidine—Thrombocytopenia—Capecitabine—breast cancer	5.72e-05	0.000362	CcSEcCtD
Ranitidine—Tachycardia—Capecitabine—breast cancer	5.71e-05	0.000361	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—breast cancer	5.67e-05	0.000358	CcSEcCtD
Ranitidine—Urticaria—Paclitaxel—breast cancer	5.66e-05	0.000358	CcSEcCtD
Ranitidine—Hyperhidrosis—Capecitabine—breast cancer	5.65e-05	0.000357	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—breast cancer	5.64e-05	0.000357	CcSEcCtD
Ranitidine—Abdominal pain—Paclitaxel—breast cancer	5.63e-05	0.000356	CcSEcCtD
Ranitidine—Body temperature increased—Paclitaxel—breast cancer	5.63e-05	0.000356	CcSEcCtD
Ranitidine—Vomiting—Mitoxantrone—breast cancer	5.55e-05	0.000351	CcSEcCtD
Ranitidine—Vomiting—Irinotecan—breast cancer	5.55e-05	0.000351	CcSEcCtD
Ranitidine—Dizziness—Fluorouracil—breast cancer	5.53e-05	0.00035	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—breast cancer	5.51e-05	0.000349	CcSEcCtD
Ranitidine—Rash—Mitoxantrone—breast cancer	5.51e-05	0.000348	CcSEcCtD
Ranitidine—Rash—Irinotecan—breast cancer	5.51e-05	0.000348	CcSEcCtD
Ranitidine—Dermatitis—Mitoxantrone—breast cancer	5.5e-05	0.000348	CcSEcCtD
Ranitidine—Dermatitis—Irinotecan—breast cancer	5.5e-05	0.000348	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.5e-05	0.000348	CcSEcCtD
Ranitidine—Headache—Mitoxantrone—breast cancer	5.47e-05	0.000346	CcSEcCtD
Ranitidine—Headache—Irinotecan—breast cancer	5.47e-05	0.000346	CcSEcCtD
Ranitidine—Hypotension—Capecitabine—breast cancer	5.46e-05	0.000345	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—breast cancer	5.46e-05	0.000345	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—breast cancer	5.42e-05	0.000343	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—breast cancer	5.41e-05	0.000342	CcSEcCtD
Ranitidine—Vomiting—Gemcitabine—breast cancer	5.41e-05	0.000342	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—breast cancer	5.4e-05	0.000341	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—breast cancer	5.38e-05	0.00034	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—breast cancer	5.37e-05	0.000339	CcSEcCtD
Ranitidine—Rash—Gemcitabine—breast cancer	5.37e-05	0.000339	CcSEcCtD
Ranitidine—Dermatitis—Gemcitabine—breast cancer	5.36e-05	0.000339	CcSEcCtD
Ranitidine—Erythema—Methotrexate—breast cancer	5.33e-05	0.000337	CcSEcCtD
Ranitidine—Headache—Gemcitabine—breast cancer	5.33e-05	0.000337	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.33e-05	0.000337	CcSEcCtD
Ranitidine—Vomiting—Fluorouracil—breast cancer	5.32e-05	0.000336	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—breast cancer	5.3e-05	0.000335	CcSEcCtD
Ranitidine—Insomnia—Capecitabine—breast cancer	5.29e-05	0.000334	CcSEcCtD
Ranitidine—Rash—Fluorouracil—breast cancer	5.28e-05	0.000334	CcSEcCtD
Ranitidine—Dermatitis—Fluorouracil—breast cancer	5.27e-05	0.000333	CcSEcCtD
Ranitidine—Hypersensitivity—Paclitaxel—breast cancer	5.25e-05	0.000332	CcSEcCtD
Ranitidine—Headache—Fluorouracil—breast cancer	5.24e-05	0.000331	CcSEcCtD
Ranitidine—Dyspnoea—Capecitabine—breast cancer	5.21e-05	0.00033	CcSEcCtD
Ranitidine—Nausea—Irinotecan—breast cancer	5.19e-05	0.000328	CcSEcCtD
Ranitidine—Nausea—Mitoxantrone—breast cancer	5.19e-05	0.000328	CcSEcCtD
Ranitidine—Pain—Docetaxel—breast cancer	5.16e-05	0.000327	CcSEcCtD
Ranitidine—Constipation—Docetaxel—breast cancer	5.16e-05	0.000327	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—breast cancer	5.12e-05	0.000324	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—breast cancer	5.07e-05	0.00032	CcSEcCtD
Ranitidine—Nausea—Gemcitabine—breast cancer	5.05e-05	0.00032	CcSEcCtD
Ranitidine—Pruritus—Paclitaxel—breast cancer	5.04e-05	0.000319	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—breast cancer	5.03e-05	0.000318	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—breast cancer	5.02e-05	0.000317	CcSEcCtD
Ranitidine—Pain—Capecitabine—breast cancer	5e-05	0.000316	CcSEcCtD
Ranitidine—Constipation—Capecitabine—breast cancer	5e-05	0.000316	CcSEcCtD
Ranitidine—Erythema—Epirubicin—breast cancer	4.99e-05	0.000316	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—breast cancer	4.98e-05	0.000315	CcSEcCtD
Ranitidine—Nausea—Fluorouracil—breast cancer	4.97e-05	0.000314	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—breast cancer	4.95e-05	0.000313	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—breast cancer	4.93e-05	0.000312	CcSEcCtD
Ranitidine—Diarrhoea—Paclitaxel—breast cancer	4.87e-05	0.000308	CcSEcCtD
Ranitidine—Feeling abnormal—Capecitabine—breast cancer	4.82e-05	0.000305	CcSEcCtD
Ranitidine—Malaise—Methotrexate—breast cancer	4.81e-05	0.000304	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—breast cancer	4.79e-05	0.000303	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—breast cancer	4.77e-05	0.000302	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—breast cancer	4.77e-05	0.000302	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—breast cancer	4.77e-05	0.000302	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—breast cancer	4.74e-05	0.0003	CcSEcCtD
Ranitidine—Dizziness—Paclitaxel—breast cancer	4.71e-05	0.000298	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—breast cancer	4.7e-05	0.000297	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—breast cancer	4.69e-05	0.000296	CcSEcCtD
Ranitidine—Urticaria—Capecitabine—breast cancer	4.64e-05	0.000294	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—breast cancer	4.63e-05	0.000293	CcSEcCtD
Ranitidine—Body temperature increased—Capecitabine—breast cancer	4.62e-05	0.000292	CcSEcCtD
Ranitidine—Abdominal pain—Capecitabine—breast cancer	4.62e-05	0.000292	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—breast cancer	4.62e-05	0.000292	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—breast cancer	4.61e-05	0.000292	CcSEcCtD
Ranitidine—Agitation—Epirubicin—breast cancer	4.59e-05	0.00029	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—breast cancer	4.54e-05	0.000287	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—breast cancer	4.54e-05	0.000287	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—breast cancer	4.54e-05	0.000287	CcSEcCtD
Ranitidine—Vomiting—Paclitaxel—breast cancer	4.53e-05	0.000286	CcSEcCtD
Ranitidine—Malaise—Epirubicin—breast cancer	4.5e-05	0.000285	CcSEcCtD
Ranitidine—Rash—Paclitaxel—breast cancer	4.49e-05	0.000284	CcSEcCtD
Ranitidine—Dermatitis—Paclitaxel—breast cancer	4.49e-05	0.000284	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—breast cancer	4.49e-05	0.000284	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—breast cancer	4.48e-05	0.000284	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—breast cancer	4.47e-05	0.000282	CcSEcCtD
Ranitidine—Headache—Paclitaxel—breast cancer	4.46e-05	0.000282	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—breast cancer	4.45e-05	0.000281	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—breast cancer	4.39e-05	0.000277	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—breast cancer	4.35e-05	0.000275	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—breast cancer	4.35e-05	0.000275	CcSEcCtD
Ranitidine—Hypersensitivity—Capecitabine—breast cancer	4.31e-05	0.000272	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—breast cancer	4.28e-05	0.000271	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—breast cancer	4.27e-05	0.00027	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—breast cancer	4.27e-05	0.00027	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—breast cancer	4.26e-05	0.000269	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—breast cancer	4.25e-05	0.000269	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—breast cancer	4.25e-05	0.000269	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—breast cancer	4.25e-05	0.000269	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—breast cancer	4.24e-05	0.000268	CcSEcCtD
Ranitidine—Nausea—Paclitaxel—breast cancer	4.23e-05	0.000268	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—breast cancer	4.21e-05	0.000266	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—breast cancer	4.2e-05	0.000265	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—breast cancer	4.16e-05	0.000263	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—breast cancer	4.15e-05	0.000262	CcSEcCtD
Ranitidine—Pruritus—Capecitabine—breast cancer	4.14e-05	0.000262	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—breast cancer	4.13e-05	0.000261	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—breast cancer	4.13e-05	0.000261	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—breast cancer	4.11e-05	0.00026	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—breast cancer	4.07e-05	0.000258	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—breast cancer	4.07e-05	0.000257	CcSEcCtD
Ranitidine—Diarrhoea—Capecitabine—breast cancer	4e-05	0.000253	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—breast cancer	3.99e-05	0.000252	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—breast cancer	3.99e-05	0.000252	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—breast cancer	3.98e-05	0.000251	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.97e-05	0.000251	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—breast cancer	3.94e-05	0.000249	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—breast cancer	3.94e-05	0.000249	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—breast cancer	3.93e-05	0.000249	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—breast cancer	3.93e-05	0.000249	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—breast cancer	3.93e-05	0.000249	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—breast cancer	3.88e-05	0.000246	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—breast cancer	3.88e-05	0.000245	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—breast cancer	3.87e-05	0.000245	CcSEcCtD
Ranitidine—Dizziness—Capecitabine—breast cancer	3.87e-05	0.000244	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—breast cancer	3.84e-05	0.000243	CcSEcCtD
Ranitidine—Rash—Docetaxel—breast cancer	3.81e-05	0.000241	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—breast cancer	3.81e-05	0.000241	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—breast cancer	3.8e-05	0.000241	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—breast cancer	3.8e-05	0.00024	CcSEcCtD
Ranitidine—Headache—Docetaxel—breast cancer	3.78e-05	0.000239	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—breast cancer	3.77e-05	0.000238	CcSEcCtD
Ranitidine—Pain—Methotrexate—breast cancer	3.72e-05	0.000235	CcSEcCtD
Ranitidine—Vomiting—Capecitabine—breast cancer	3.72e-05	0.000235	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.71e-05	0.000235	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—breast cancer	3.69e-05	0.000233	CcSEcCtD
Ranitidine—Rash—Capecitabine—breast cancer	3.69e-05	0.000233	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—breast cancer	3.68e-05	0.000233	CcSEcCtD
Ranitidine—Dermatitis—Capecitabine—breast cancer	3.68e-05	0.000233	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—breast cancer	3.68e-05	0.000233	CcSEcCtD
Ranitidine—Headache—Capecitabine—breast cancer	3.66e-05	0.000232	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—breast cancer	3.64e-05	0.00023	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—breast cancer	3.63e-05	0.00023	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—breast cancer	3.62e-05	0.000229	CcSEcCtD
Ranitidine—Nausea—Docetaxel—breast cancer	3.59e-05	0.000227	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—breast cancer	3.59e-05	0.000227	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—breast cancer	3.52e-05	0.000223	CcSEcCtD
Ranitidine—Pain—Epirubicin—breast cancer	3.48e-05	0.00022	CcSEcCtD
Ranitidine—Constipation—Epirubicin—breast cancer	3.48e-05	0.00022	CcSEcCtD
Ranitidine—Nausea—Capecitabine—breast cancer	3.47e-05	0.00022	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—breast cancer	3.46e-05	0.000219	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—breast cancer	3.44e-05	0.000218	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—breast cancer	3.44e-05	0.000218	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.43e-05	0.000217	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—breast cancer	3.41e-05	0.000216	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—breast cancer	3.36e-05	0.000212	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—breast cancer	3.36e-05	0.000212	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—breast cancer	3.35e-05	0.000212	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—breast cancer	3.24e-05	0.000205	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—breast cancer	3.22e-05	0.000204	CcSEcCtD
Ranitidine—Pain—Doxorubicin—breast cancer	3.22e-05	0.000204	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—breast cancer	3.22e-05	0.000204	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—breast cancer	3.22e-05	0.000204	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—breast cancer	3.21e-05	0.000203	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—breast cancer	3.11e-05	0.000196	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—breast cancer	3.08e-05	0.000195	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—breast cancer	3e-05	0.00019	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—breast cancer	2.99e-05	0.000189	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—breast cancer	2.98e-05	0.000188	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—breast cancer	2.98e-05	0.000188	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—breast cancer	2.98e-05	0.000188	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—breast cancer	2.88e-05	0.000182	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—breast cancer	2.88e-05	0.000182	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—breast cancer	2.79e-05	0.000176	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—breast cancer	2.78e-05	0.000176	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—breast cancer	2.77e-05	0.000175	CcSEcCtD
Ranitidine—Rash—Methotrexate—breast cancer	2.74e-05	0.000174	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—breast cancer	2.74e-05	0.000173	CcSEcCtD
Ranitidine—Headache—Methotrexate—breast cancer	2.73e-05	0.000172	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—breast cancer	2.69e-05	0.00017	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—breast cancer	2.67e-05	0.000169	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—breast cancer	2.59e-05	0.000164	CcSEcCtD
Ranitidine—Nausea—Methotrexate—breast cancer	2.59e-05	0.000163	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—breast cancer	2.58e-05	0.000163	CcSEcCtD
Ranitidine—Rash—Epirubicin—breast cancer	2.57e-05	0.000162	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—breast cancer	2.57e-05	0.000162	CcSEcCtD
Ranitidine—Headache—Epirubicin—breast cancer	2.55e-05	0.000161	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—breast cancer	2.49e-05	0.000158	CcSEcCtD
Ranitidine—Nausea—Epirubicin—breast cancer	2.42e-05	0.000153	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—breast cancer	2.4e-05	0.000152	CcSEcCtD
Ranitidine—Rash—Doxorubicin—breast cancer	2.38e-05	0.00015	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—breast cancer	2.37e-05	0.00015	CcSEcCtD
Ranitidine—Headache—Doxorubicin—breast cancer	2.36e-05	0.000149	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—breast cancer	2.24e-05	0.000142	CcSEcCtD
Ranitidine—HRH2—Signaling Pathways—PTEN—breast cancer	4.37e-06	5.84e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.36e-06	5.83e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NCOR1—breast cancer	4.34e-06	5.81e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.34e-06	5.81e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—breast cancer	4.34e-06	5.81e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CPT1A—breast cancer	4.32e-06	5.77e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTR—breast cancer	4.32e-06	5.77e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCG2—breast cancer	4.32e-06	5.77e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.29e-06	5.74e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA2—breast cancer	4.29e-06	5.73e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX2—breast cancer	4.29e-06	5.73e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SLC2A1—breast cancer	4.28e-06	5.72e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NQO1—breast cancer	4.28e-06	5.72e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP3A4—breast cancer	4.27e-06	5.71e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK8—breast cancer	4.27e-06	5.71e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—breast cancer	4.26e-06	5.7e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.25e-06	5.68e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—FASN—breast cancer	4.24e-06	5.67e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HPGDS—breast cancer	4.23e-06	5.66e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX4—breast cancer	4.23e-06	5.66e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SULT1A1—breast cancer	4.23e-06	5.66e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BCHE—breast cancer	4.22e-06	5.65e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HBA1—breast cancer	4.21e-06	5.63e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1B1—breast cancer	4.2e-06	5.62e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC5A5—breast cancer	4.17e-06	5.58e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP3A4—breast cancer	4.17e-06	5.57e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX1—breast cancer	4.16e-06	5.56e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—breast cancer	4.15e-06	5.55e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH1—breast cancer	4.13e-06	5.53e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA1—breast cancer	4.13e-06	5.53e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.12e-06	5.51e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A1—breast cancer	4.12e-06	5.5e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ACHE—breast cancer	4.11e-06	5.49e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—breast cancer	4.11e-06	5.49e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1B1—breast cancer	4.1e-06	5.48e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NAT2—breast cancer	4.09e-06	5.47e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ERCC2—breast cancer	4.08e-06	5.46e-05	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	4.08e-06	5.45e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—breast cancer	4.05e-06	5.41e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NQO1—breast cancer	4.03e-06	5.39e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC2A1—breast cancer	4.03e-06	5.39e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—HSP90AA1—breast cancer	4.02e-06	5.37e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOA1—breast cancer	4.01e-06	5.36e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—STK11—breast cancer	3.95e-06	5.28e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP19A1—breast cancer	3.95e-06	5.28e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—breast cancer	3.94e-06	5.27e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.93e-06	5.25e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOA1—breast cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—breast cancer	3.91e-06	5.22e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP17A1—breast cancer	3.89e-06	5.2e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1B1—breast cancer	3.86e-06	5.16e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—STK11—breast cancer	3.85e-06	5.15e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP19A1—breast cancer	3.85e-06	5.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO1—breast cancer	3.85e-06	5.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS1—breast cancer	3.85e-06	5.15e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—breast cancer	3.84e-06	5.13e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.83e-06	5.13e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.79e-06	5.06e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.79e-06	5.06e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2D6—breast cancer	3.77e-06	5.05e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK3—breast cancer	3.73e-06	4.99e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.71e-06	4.96e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA2—breast cancer	3.7e-06	4.95e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOA1—breast cancer	3.69e-06	4.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—COMT—breast cancer	3.67e-06	4.91e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—breast cancer	3.65e-06	4.88e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—breast cancer	3.65e-06	4.88e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—STK11—breast cancer	3.63e-06	4.86e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP19A1—breast cancer	3.63e-06	4.86e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—breast cancer	3.63e-06	4.85e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—breast cancer	3.62e-06	4.84e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—HMOX1—breast cancer	3.6e-06	4.82e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—breast cancer	3.6e-06	4.82e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ITPR1—breast cancer	3.6e-06	4.81e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—FASN—breast cancer	3.59e-06	4.8e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MED12—breast cancer	3.58e-06	4.79e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—DPYD—breast cancer	3.58e-06	4.79e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—COMT—breast cancer	3.58e-06	4.79e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BCHE—breast cancer	3.58e-06	4.78e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—breast cancer	3.57e-06	4.77e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—breast cancer	3.55e-06	4.75e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAV1—breast cancer	3.54e-06	4.73e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC5A5—breast cancer	3.53e-06	4.73e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALDOA—breast cancer	3.53e-06	4.72e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—HMOX1—breast cancer	3.52e-06	4.7e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ITPR1—breast cancer	3.51e-06	4.69e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCB1—breast cancer	3.46e-06	4.62e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NOS3—breast cancer	3.45e-06	4.61e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA3—breast cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC2A1—breast cancer	3.41e-06	4.56e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NQO1—breast cancer	3.41e-06	4.56e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC2A2—breast cancer	3.4e-06	4.55e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—breast cancer	3.4e-06	4.54e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—COMT—breast cancer	3.38e-06	4.51e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—breast cancer	3.36e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—breast cancer	3.36e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.36e-06	4.49e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOR1—breast cancer	3.36e-06	4.49e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—breast cancer	3.35e-06	4.48e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.34e-06	4.47e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTR—breast cancer	3.33e-06	4.46e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CPT1A—breast cancer	3.33e-06	4.46e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCG2—breast cancer	3.33e-06	4.46e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP3A4—breast cancer	3.33e-06	4.45e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—breast cancer	3.32e-06	4.43e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HMOX1—breast cancer	3.31e-06	4.43e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.31e-06	4.43e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ITPR1—breast cancer	3.31e-06	4.42e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PLA2G4A—breast cancer	3.28e-06	4.38e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOR1—breast cancer	3.28e-06	4.38e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—breast cancer	3.28e-06	4.38e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1B1—breast cancer	3.27e-06	4.38e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HPGDS—breast cancer	3.27e-06	4.37e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HBA1—breast cancer	3.25e-06	4.34e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—breast cancer	3.23e-06	4.31e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX1—breast cancer	3.22e-06	4.3e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.21e-06	4.29e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A1—breast cancer	3.18e-06	4.26e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—breast cancer	3.18e-06	4.25e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCB1—breast cancer	3.18e-06	4.25e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—breast cancer	3.17e-06	4.24e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ACHE—breast cancer	3.17e-06	4.24e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ERCC2—breast cancer	3.16e-06	4.22e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—breast cancer	3.15e-06	4.21e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX1—breast cancer	3.14e-06	4.2e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—breast cancer	3.12e-06	4.18e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA1—breast cancer	3.12e-06	4.17e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A1—breast cancer	3.11e-06	4.15e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.09e-06	4.13e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—breast cancer	3.09e-06	4.13e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOR1—breast cancer	3.09e-06	4.13e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ERCC2—breast cancer	3.08e-06	4.12e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—breast cancer	3.08e-06	4.12e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—STK11—breast cancer	3.08e-06	4.11e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP19A1—breast cancer	3.08e-06	4.11e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP17A1—breast cancer	3e-06	4.01e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—breast cancer	2.98e-06	3.98e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS1—breast cancer	2.97e-06	3.97e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO1—breast cancer	2.97e-06	3.97e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—breast cancer	2.97e-06	3.97e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX1—breast cancer	2.96e-06	3.95e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.93e-06	3.91e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.91e-06	3.89e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ERCC2—breast cancer	2.9e-06	3.88e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—breast cancer	2.9e-06	3.87e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.89e-06	3.86e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—COMT—breast cancer	2.86e-06	3.82e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA2—breast cancer	2.86e-06	3.82e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—breast cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—breast cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—breast cancer	2.84e-06	3.79e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HMOX1—breast cancer	2.81e-06	3.75e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ITPR1—breast cancer	2.8e-06	3.75e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—breast cancer	2.8e-06	3.74e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—FASN—breast cancer	2.77e-06	3.71e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BCHE—breast cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—breast cancer	2.75e-06	3.68e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAV1—breast cancer	2.74e-06	3.66e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—breast cancer	2.73e-06	3.65e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—breast cancer	2.73e-06	3.65e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.73e-06	3.65e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCB1—breast cancer	2.7e-06	3.6e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NOS3—breast cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAV1—breast cancer	2.67e-06	3.57e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—breast cancer	2.65e-06	3.54e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NQO1—breast cancer	2.63e-06	3.52e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC2A1—breast cancer	2.63e-06	3.52e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—breast cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOR1—breast cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1B1—breast cancer	2.53e-06	3.38e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAV1—breast cancer	2.52e-06	3.37e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—breast cancer	2.52e-06	3.36e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX1—breast cancer	2.51e-06	3.35e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—breast cancer	2.49e-06	3.33e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1A1—breast cancer	2.48e-06	3.32e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.48e-06	3.31e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—breast cancer	2.47e-06	3.3e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ERCC2—breast cancer	2.46e-06	3.29e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—breast cancer	2.45e-06	3.27e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—breast cancer	2.43e-06	3.25e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA1—breast cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—STK11—breast cancer	2.37e-06	3.17e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP19A1—breast cancer	2.37e-06	3.17e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—breast cancer	2.31e-06	3.09e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.29e-06	3.07e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—COMT—breast cancer	2.21e-06	2.95e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—breast cancer	2.2e-06	2.94e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—breast cancer	2.19e-06	2.93e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HMOX1—breast cancer	2.17e-06	2.9e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—breast cancer	2.16e-06	2.89e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ITPR1—breast cancer	2.16e-06	2.89e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—breast cancer	2.14e-06	2.86e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—breast cancer	2.14e-06	2.85e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAV1—breast cancer	2.13e-06	2.85e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—breast cancer	2.11e-06	2.82e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCB1—breast cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NOS3—breast cancer	2.07e-06	2.77e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—breast cancer	2.04e-06	2.73e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NOS3—breast cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—breast cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOR1—breast cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—breast cancer	1.99e-06	2.66e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.94e-06	2.6e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—breast cancer	1.94e-06	2.59e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX1—breast cancer	1.93e-06	2.59e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.91e-06	2.56e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.91e-06	2.55e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NOS3—breast cancer	1.9e-06	2.54e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ERCC2—breast cancer	1.9e-06	2.54e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—breast cancer	1.89e-06	2.53e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—breast cancer	1.86e-06	2.49e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—breast cancer	1.85e-06	2.47e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—breast cancer	1.78e-06	2.39e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—breast cancer	1.74e-06	2.33e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.71e-06	2.28e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—breast cancer	1.69e-06	2.25e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—breast cancer	1.65e-06	2.21e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAV1—breast cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NOS3—breast cancer	1.61e-06	2.16e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—breast cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—breast cancer	1.58e-06	2.12e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—breast cancer	1.52e-06	2.03e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—breast cancer	1.51e-06	2.01e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.5e-06	2e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.49e-06	1.99e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—breast cancer	1.47e-06	1.97e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.32e-06	1.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—breast cancer	1.3e-06	1.74e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—breast cancer	1.29e-06	1.72e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NOS3—breast cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—breast cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.16e-06	1.56e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.15e-06	1.54e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—breast cancer	1.14e-06	1.52e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—breast cancer	1.14e-06	1.52e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.07e-06	1.43e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—breast cancer	9.93e-07	1.33e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—breast cancer	9.51e-07	1.27e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—breast cancer	9.29e-07	1.24e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—breast cancer	9.07e-07	1.21e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—breast cancer	8.75e-07	1.17e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—breast cancer	7.41e-07	9.91e-06	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—breast cancer	7e-07	9.36e-06	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—breast cancer	5.72e-07	7.65e-06	CbGpPWpGaD
